Robert Gitonga

Epidemiology & Real-World Research, and Biostatistics, Parexel International, Durham, United States

Poster(s):

• (B-106) Adherence to risk minimization measures for alemtuzumab use in Multiple Sclerosis: a drug utilisation study in four European countries
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET